| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/15/1999 | US5911997 Relaxin-like factor and methods and uses thereof |
| 06/15/1999 | US5911996 Fusion proteins from actinobacillus, soluble on sodium lauryl sarcosinate derived by genetic engineering for immunity |
| 06/15/1999 | US5911991 Malarial binding site in duffy blood group protein |
| 06/15/1999 | US5911990 Restoring normal immune response by administering peptide which stimulates production of interferon-gamma and interleukin-5 while suppressing production of immunoglobulin-g and interleukins-5,-6 and-10 |
| 06/15/1999 | US5911989 Antibodies |
| 06/15/1999 | US5911987 Cell surface protein and effector cell bonding reagent |
| 06/15/1999 | US5911982 Hz-1 virus persistence-associated-gene 1 (PAG1) promoter uses therefor, and compositions containing same or products therefrom |
| 06/15/1999 | CA2128612C Antimicrobial agents and method for treating products therewith |
| 06/15/1999 | CA2088068C Protein structure of the plant toxin gelonin |
| 06/15/1999 | CA2014465C Herpesvirus recombinant poxvirus vaccine |
| 06/12/1999 | CA2218446A1 New candida albicans kre9 and uses thereof |
| 06/10/1999 | WO1999028876A2 Hydrophobically-modified protein compositions and methods |
| 06/10/1999 | WO1999028750A1 Frnk proteins in the treatment of tumor cells |
| 06/10/1999 | WO1999028749A1 USES OF p27 IN PROSTATE CANCER |
| 06/10/1999 | WO1999028493A2 Method for identifying inhibitors of g-protein coupled receptor hibef51 |
| 06/10/1999 | WO1999028492A1 A method of finding agonist and antagonist to human 11cb splice variant |
| 06/10/1999 | WO1999028484A1 Proteinase inhibitor fusion proteins |
| 06/10/1999 | WO1999028482A2 Single-chain recombinant complexes of hepatitis c virus ns3 protease and ns4a cofactor peptide |
| 06/10/1999 | WO1999028478A1 Preparation and use of recombinant influenza a virus m2 constructs and vaccines |
| 06/10/1999 | WO1999028477A1 A NOVEL cry1 GENE FROM $i(BACILLUS THURINGIENSIS) |
| 06/10/1999 | WO1999028476A1 Dna encoding phage resistance protein |
| 06/10/1999 | WO1999028475A2 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
| 06/10/1999 | WO1999028474A2 Chemokine variants and methods of use |
| 06/10/1999 | WO1999028473A1 A cDNA ENCODING C6 β-CHEMOKINE LEUKOTACTIN-1(Lkn-1) ISOLATED FROM HUMAN |
| 06/10/1999 | WO1999028472A1 A cDNA ENCODING C6 β-CHEMOKINE LEUKOTACTIN-1(Lkn-1) ISOLATED FROM HUMAN |
| 06/10/1999 | WO1999028470A1 G-protein coupled receptors and uses therefor |
| 06/10/1999 | WO1999028469A1 Compositions and methods for inducing gene expression |
| 06/10/1999 | WO1999028468A1 Modulating b lymphocyte chemokine/receptor interactions |
| 06/10/1999 | WO1999028467A1 Human thyroid protein zsig45 and dna encoding same |
| 06/10/1999 | WO1999028466A1 Compositions and methods of use of het |
| 06/10/1999 | WO1999028465A2 Pias molecules that recognize and bind stat proteins and uses thereof |
| 06/10/1999 | WO1999028464A2 Cdnas and proteins belonging to the bhlh-pas superfamily of transcription regulators and methods of use |
| 06/10/1999 | WO1999028462A2 Polypeptides and nucleic acids encoding the same |
| 06/10/1999 | WO1999028461A2 Methods and means for inducing apoptosis by interfering with bip-like proteins |
| 06/10/1999 | WO1999028460A2 Molecules interacting with apoptin |
| 06/10/1999 | WO1999028458A1 Gene originating in human fetal chondrocytes |
| 06/10/1999 | WO1999028457A1 Tsa305 gene |
| 06/10/1999 | WO1999028456A1 Splice variants for human 5-ht4 serotonin receptor and their applications, in particular for screening |
| 06/10/1999 | WO1999028455A1 Method for preparing polypeptides with appropriate glycosilation |
| 06/10/1999 | WO1999028454A1 An active hedgehog-protein-mutant, a process for its preparation and its use for pharmaceutical purposes |
| 06/10/1999 | WO1999028453A2 Transgenic non-human mammals with an oncogenic mutant of raf gene 1 |
| 06/10/1999 | WO1999028445A1 Live attenuated influenza vaccine |
| 06/10/1999 | WO1999028442A1 CREATION OF HETEROIMMUNITY AMONGST CTXζ: METHODS AND COMPOUNDS FOR THE CONSTRUCTION OF IMPROVED V. CHOLERAE VACCINES |
| 06/10/1999 | WO1999028440A1 Nucleic acid encoding mammalian ubr1 |
| 06/10/1999 | WO1999028439A2 Erythrovirus and its applications |
| 06/10/1999 | WO1999028349A2 CELLS EXPRESSING ANTI-Fc RECEPTOR BINDING COMPONENTS |
| 06/10/1999 | WO1999028348A1 Oxygen-transporting albumin-based blood replacement composition and blood volume expander |
| 06/10/1999 | WO1999028347A1 Method of designing agonists and antagonists to igf receptor |
| 06/10/1999 | WO1999028346A1 Erythropoietin with high specific activity |
| 06/10/1999 | WO1999028345A1 Conjugates useful in the treatment of prostate cancer |
| 06/10/1999 | WO1999028344A2 Synthetic peptides containing citrulline recognized by rheumatoid arthritis sera as tools for diagnosis and treatment |
| 06/10/1999 | WO1999028343A2 Hydrophobically-modified protein compositions and methods |
| 06/10/1999 | WO1999028342A2 Low-voltage activated calcium channel compositions and methods |
| 06/10/1999 | WO1999028341A2 Maintenance of smooth muscle integrity by morphogenic proteins |
| 06/10/1999 | WO1999028340A2 Cruciform binding protein |
| 06/10/1999 | WO1999028339A1 Backbone cyclic peptide fragments and their analogs derived from pban 1-33, useful as insecticides |
| 06/10/1999 | WO1999028338A1 Inhibition of nuclear import by backbone cyclic peptide analogs |
| 06/10/1999 | WO1999028335A1 Secreted proteins and polynucleotides encoding them |
| 06/10/1999 | WO1999028334A1 Novel genes encoding proteins involved in mitotic checkpoint control and methods of use thereof |
| 06/10/1999 | WO1999027968A2 Oxidative method for attachment of glycoproteins or glycopeptides to surfaces of medical devices |
| 06/10/1999 | WO1999027963A1 Antibody production methods relating to disruption of peripheral tolerance in b lymphocytes |
| 06/10/1999 | WO1999027958A2 Hiv-1 tat, or derivatives thereof for prophylactic and therapeutic vaccination |
| 06/10/1999 | WO1999027954A2 Mixed lipopeptide micelles for inducing an immune response |
| 06/10/1999 | WO1999027944A1 Prevention and treatment of amyloidogenic disease |
| 06/10/1999 | WO1999027889A2 Non-toxic immune stimulating enterotoxin compositions |
| 06/10/1999 | WO1999015684A3 Expression of genes in hematopoietic stem cells in hischaemic conditions |
| 06/10/1999 | WO1999015669A3 Clostridium toxin, and method for preparing immunogenic compositions |
| 06/10/1999 | WO1999015659A3 Human ubiquitin-conjugating enzymes |
| 06/10/1999 | WO1999015658A3 Human regulatory molecules |
| 06/10/1999 | WO1999014331A3 Cyclin-dependent kinase inhibitors and uses thereof |
| 06/10/1999 | WO1999014241A3 Compositions and methods for the treatment of immune related diseases |
| 06/10/1999 | WO1999013095A3 Use of multivalent chimeric peptide-loaded, mhc/ig molecules to detect, activate or suppress antigen-specific t cell-dependent immune responses |
| 06/10/1999 | WO1999013073A3 Viral vector system capable of expressing an apoptosis-associated gene |
| 06/10/1999 | WO1999010375A3 Vaccine against hpv |
| 06/10/1999 | WO1999007737A3 Lsr receptor, cloning and uses |
| 06/10/1999 | WO1999006545A8 Composition and method for the detection of diseases associated with amyloid-like fibril or protein aggregate formation |
| 06/10/1999 | WO1999005175A3 Diagnosis and treatment of diseases using anti-anti-t-cell receptor vbeta anti-bodies or peptides which are recognized by said antibodies, and endocrine secretion regulatory protein i (esrp1) |
| 06/10/1999 | WO1998058955A9 Nuclear matrix targeting peptides and uses therefor |
| 06/10/1999 | WO1998045421A3 Hepatitis b virus mutations |
| 06/10/1999 | WO1998004582A8 Isolated peptides derived from mage-2 |
| 06/10/1999 | DE19754103A1 New packaging cell line for E1-deleted adenovirus |
| 06/10/1999 | CA2408167A1 Pro243 polypeptides and nucleic acids encoding the same |
| 06/10/1999 | CA2314423A1 Maintenance of smooth muscle integrity by morphogenic proteins |
| 06/10/1999 | CA2313243A1 Nucleic acid encoding mammalian ubr1 |
| 06/10/1999 | CA2312920A1 Prevention and treatment of amyloidogenic disease |
| 06/10/1999 | CA2312738A1 Non-toxic immune stimulating enterotoxin compositions |
| 06/10/1999 | CA2312478A1 G-protein coupled receptors and uses therefor |
| 06/10/1999 | CA2312290A1 Secreted proteins and polynucleotides encoding them |
| 06/10/1999 | CA2312195A1 Low-voltage activated calcium channel compositions and methods |
| 06/10/1999 | CA2312050A1 Proteinase inhibitor fusion proteins |
| 06/10/1999 | CA2312048A1 Human thyroid protein zsig45 and dna encoding same |
| 06/10/1999 | CA2312043A1 Mixed lipopeptide micelles for inducing an immune response |
| 06/10/1999 | CA2312009A1 An active hedgehog-protein-mutant, a process for its preparation and its use for pharmaceutical purposes |
| 06/10/1999 | CA2312007A1 Methods and means for inducing apoptosis by interfering with bip-like proteins |
| 06/10/1999 | CA2311926A1 Method of designing agonists and antagonists to igf receptor |
| 06/10/1999 | CA2311768A1 Inhibition of nuclear import by backbone cyclic peptide analogs |
| 06/10/1999 | CA2311647A1 Hiv-1 tat, or derivatives thereof for prophylactic and therapeutic vaccination |
| 06/10/1999 | CA2311640A1 Polypeptides and nucleic acids encoding the same |
| 06/10/1999 | CA2311615A1 Conjugates useful in the treatment of prostate cancer |
| 06/10/1999 | CA2311611A1 Molecules interacting with apoptin |